SrasV1, Ncbi, Merge, bibRecord, 002990

SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.

Identifieur interne : 002990 ( Ncbi/Merge ); précédent : 002989; suivant : 002991

SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.

Auteurs : Dong Yang [États-Unis] ; Pinghua Liu [États-Unis] ; Elyse V. Wudeck [États-Unis] ; David P. Giedroc [États-Unis] ; Julian L. Leibowitz [États-Unis]

Source :

Virology [ 1096-0341 ] ; 2015.

RBID : pubmed:25462342

Descripteurs français

KwdFr :
- ARN viral (), ARN viral (métabolisme), Animaux, Conformation d'acide nucléique, Protéines virales non structurales (génétique), Protéines virales non structurales (métabolisme), Régions 5' non traduites (génétique), Régulation de l'expression des gènes viraux (physiologie), Souris, Virus de l'hépatite murine (génétique), Virus de l'hépatite murine (métabolisme).
MESH :
- génétique : Protéines virales non structurales, Régions 5' non traduites, Virus de l'hépatite murine.
- métabolisme : ARN viral, Protéines virales non structurales, Virus de l'hépatite murine.
- physiologie : Régulation de l'expression des gènes viraux.
- ARN viral, Animaux, Conformation d'acide nucléique, Souris.

English descriptors

KwdEn :
- 5' Untranslated Regions (genetics), Animals, Gene Expression Regulation, Viral (physiology), Mice, Murine hepatitis virus (genetics), Murine hepatitis virus (metabolism), Nucleic Acid Conformation, RNA, Viral (chemistry), RNA, Viral (metabolism), Viral Nonstructural Proteins (genetics), Viral Nonstructural Proteins (metabolism).
MESH :
- chemical , chemistry : RNA, Viral.
- chemical , genetics : 5' Untranslated Regions, Viral Nonstructural Proteins.
- genetics : Murine hepatitis virus.
- metabolism : Murine hepatitis virus, RNA, Viral, Viral Nonstructural Proteins.
- physiology : Gene Expression Regulation, Viral.
- Animals, Mice, Nucleic Acid Conformation.

Abstract

SHAPE technology was used to analyze RNA secondary structure of the 5' most 474 nts of the MHV-A59 genome encompassing the minimal 5' cis-acting region required for defective interfering RNA replication. The structures generated were in agreement with previous characterizations of SL1 through SL4 and two recently predicted secondary structure elements, S5 and SL5A. SHAPE provided biochemical support for four additional stem-loops not previously functionally investigated in MHV. Secondary structure predictions for 5' regions of MHV-A59, BCoV and SARS-CoV were similar despite high sequence divergence. The pattern of SHAPE reactivity of in virio genomic RNA, ex virio genomic RNA, and in vitro synthesized RNA was similar, suggesting that binding of N protein or other proteins to virion RNA fails to protect the RNA from reaction with lipid permeable SHAPE reagent. Reverse genetic experiments suggested that SL5C and SL6 within the nsp1 coding sequence are not required for viral replication.

DOI: 10.1016/j.virol.2014.11.001
PubMed: 25462342

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000F00
to stream PubMed, to step Curation: 000F00
to stream PubMed, to step Checkpoint: 000D67

Links to Exploration step

pubmed:25462342

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.</title>
<author><name sortKey="Yang, Dong" sort="Yang, Dong" uniqKey="Yang D" first="Dong" last="Yang">Dong Yang</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Pinghua" sort="Liu, Pinghua" uniqKey="Liu P" first="Pinghua" last="Liu">Pinghua Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wudeck, Elyse V" sort="Wudeck, Elyse V" uniqKey="Wudeck E" first="Elyse V" last="Wudeck">Elyse V. Wudeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Giedroc, David P" sort="Giedroc, David P" uniqKey="Giedroc D" first="David P" last="Giedroc">David P. Giedroc</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Chemistry, Indiana University, Bloomington, IN 47405-7102, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, Indiana University, Bloomington, IN 47405-7102</wicri:regionArea>
<placeName><region type="state">Indiana</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leibowitz, Julian L" sort="Leibowitz, Julian L" uniqKey="Leibowitz J" first="Julian L" last="Leibowitz">Julian L. Leibowitz</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA. Electronic address: jleibowitz@tamu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25462342</idno>
<idno type="pmid">25462342</idno>
<idno type="doi">10.1016/j.virol.2014.11.001</idno>
<idno type="wicri:Area/PubMed/Corpus">000F00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F00</idno>
<idno type="wicri:Area/PubMed/Curation">000F00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F00</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D67</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D67</idno>
<idno type="wicri:Area/Ncbi/Merge">002990</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.</title>
<author><name sortKey="Yang, Dong" sort="Yang, Dong" uniqKey="Yang D" first="Dong" last="Yang">Dong Yang</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Pinghua" sort="Liu, Pinghua" uniqKey="Liu P" first="Pinghua" last="Liu">Pinghua Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wudeck, Elyse V" sort="Wudeck, Elyse V" uniqKey="Wudeck E" first="Elyse V" last="Wudeck">Elyse V. Wudeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Giedroc, David P" sort="Giedroc, David P" uniqKey="Giedroc D" first="David P" last="Giedroc">David P. Giedroc</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Chemistry, Indiana University, Bloomington, IN 47405-7102, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, Indiana University, Bloomington, IN 47405-7102</wicri:regionArea>
<placeName><region type="state">Indiana</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leibowitz, Julian L" sort="Leibowitz, Julian L" uniqKey="Leibowitz J" first="Julian L" last="Leibowitz">Julian L. Leibowitz</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA. Electronic address: jleibowitz@tamu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="eISSN">1096-0341</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>5' Untranslated Regions (genetics)</term>
<term>Animals</term>
<term>Gene Expression Regulation, Viral (physiology)</term>
<term>Mice</term>
<term>Murine hepatitis virus (genetics)</term>
<term>Murine hepatitis virus (metabolism)</term>
<term>Nucleic Acid Conformation</term>
<term>RNA, Viral (chemistry)</term>
<term>RNA, Viral (metabolism)</term>
<term>Viral Nonstructural Proteins (genetics)</term>
<term>Viral Nonstructural Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral ()</term>
<term>ARN viral (métabolisme)</term>
<term>Animaux</term>
<term>Conformation d'acide nucléique</term>
<term>Protéines virales non structurales (génétique)</term>
<term>Protéines virales non structurales (métabolisme)</term>
<term>Régions 5' non traduites (génétique)</term>
<term>Régulation de l'expression des gènes viraux (physiologie)</term>
<term>Souris</term>
<term>Virus de l'hépatite murine (génétique)</term>
<term>Virus de l'hépatite murine (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>5' Untranslated Regions</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines virales non structurales</term>
<term>Régions 5' non traduites</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Murine hepatitis virus</term>
<term>RNA, Viral</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>ARN viral</term>
<term>Protéines virales non structurales</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Régulation de l'expression des gènes viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gene Expression Regulation, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Mice</term>
<term>Nucleic Acid Conformation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ARN viral</term>
<term>Animaux</term>
<term>Conformation d'acide nucléique</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">SHAPE technology was used to analyze RNA secondary structure of the 5' most 474 nts of the MHV-A59 genome encompassing the minimal 5' cis-acting region required for defective interfering RNA replication. The structures generated were in agreement with previous characterizations of SL1 through SL4 and two recently predicted secondary structure elements, S5 and SL5A. SHAPE provided biochemical support for four additional stem-loops not previously functionally investigated in MHV. Secondary structure predictions for 5' regions of MHV-A59, BCoV and SARS-CoV were similar despite high sequence divergence. The pattern of SHAPE reactivity of in virio genomic RNA, ex virio genomic RNA, and in vitro synthesized RNA was similar, suggesting that binding of N protein or other proteins to virion RNA fails to protect the RNA from reaction with lipid permeable SHAPE reagent. Reverse genetic experiments suggested that SL5C and SL6 within the nsp1 coding sequence are not required for viral replication. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25462342</PMID>
<DateCompleted><Year>2015</Year>
<Month>03</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>475</Volume>
<PubDate><Year>2015</Year>
<Month>Jan</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.</ArticleTitle>
<Pagination><MedlinePgn>15-27</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2014.11.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0042-6822(14)00495-4</ELocationID>
<Abstract><AbstractText>SHAPE technology was used to analyze RNA secondary structure of the 5' most 474 nts of the MHV-A59 genome encompassing the minimal 5' cis-acting region required for defective interfering RNA replication. The structures generated were in agreement with previous characterizations of SL1 through SL4 and two recently predicted secondary structure elements, S5 and SL5A. SHAPE provided biochemical support for four additional stem-loops not previously functionally investigated in MHV. Secondary structure predictions for 5' regions of MHV-A59, BCoV and SARS-CoV were similar despite high sequence divergence. The pattern of SHAPE reactivity of in virio genomic RNA, ex virio genomic RNA, and in vitro synthesized RNA was similar, suggesting that binding of N protein or other proteins to virion RNA fails to protect the RNA from reaction with lipid permeable SHAPE reagent. Reverse genetic experiments suggested that SL5C and SL6 within the nsp1 coding sequence are not required for viral replication. </AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Dong</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Pinghua</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wudeck</LastName>
<ForeName>Elyse V</ForeName>
<Initials>EV</Initials>
<AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Giedroc</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo><Affiliation>Department of Chemistry, Indiana University, Bloomington, IN 47405-7102, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leibowitz</LastName>
<ForeName>Julian L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&M University, College of Medicine, 407 Reynolds Medical Building, 1114 TAMU, College Station, TX 77843-1114, USA. Electronic address: jleibowitz@tamu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 AI051493</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 AI067416</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI051493</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI067416</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505227">NSP1 protein, murine hepatitis virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="N">5' Untranslated Regions</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5′ cis-acting region</Keyword>
<Keyword MajorTopicYN="N">Betacoronavirus</Keyword>
<Keyword MajorTopicYN="N">Mouse Hepatitis Virus</Keyword>
<Keyword MajorTopicYN="N">Murine coronavirus</Keyword>
<Keyword MajorTopicYN="N">RNA secondary structure</Keyword>
<Keyword MajorTopicYN="N">SHAPE analysis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>10</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>3</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25462342</ArticleId>
<ArticleId IdType="pii">S0042-6822(14)00495-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2014.11.001</ArticleId>
<ArticleId IdType="pmc">PMC4280293</ArticleId>
<ArticleId IdType="mid">NIHMS641531</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Virology. 2005 Sep 30;340(2):209-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16051301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Jun;85(11):5593-605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21430057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(5):e65045</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23717688</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2000 Jan;81(Pt 1):181-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10640556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Nov;76(21):11065-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12368349</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Jun;77(12):6720-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12767992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035025</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1981 Oct 15;114(1):39-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7281517</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Virus Res. 1983;28:35-112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6362367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1987 Apr;157(2):565-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3029990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1988 Nov;62(11):4280-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2845140</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1988 Nov;62(11):4288-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2845141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1991 Dec;65(12):6881-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1719235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 Oct;67(10):6110-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8396672</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1993 Nov;197(1):53-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8212595</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1994 Dec;68(12):8223-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7966615</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1996 May;70(5):2720-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8627745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1996 Feb 1;216(1):174-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8614984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2005;287:1-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15609507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2005 Mar 30;127(12):4223-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15783204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Oct;79(19):12434-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16160171</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Dec;79(23):14570-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16282457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2006 Apr;117(1):17-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16503362</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Exp Med Biol. 2006;581:25-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17037499</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Nov;80(21):10600-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16920822</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jan;81(1):20-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16928755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2007 Apr 11;129(14):4144-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17367143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2007 May 11;368(4):1075-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17379242</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2007 May;13(5):763-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17353353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jul;81(14):7716-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17475638</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Dec;81(24):13587-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17898055</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2008 Mar 28;377(3):790-803</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18289557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2008 Apr 29;6(4):e96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18447581</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2008 Jul 18;380(4):608-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18561946</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Chem Soc. 2008 Sep 17;130(37):12244-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18710236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2008 Oct;14(10):1979-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18772246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):97-102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19109441</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2009 Jun;83(12):6087-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19357173</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Sep;85(17):9199-209</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21715502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2011 Sep 20;50(37):8049-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21842868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Protoc. 2011 Nov;6(11):1683-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21979276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2012 Mar 2;287(10):7063-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22241479</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Apr;86(8):4631-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22345457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2009 Jul 17;390(3):547-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19445952</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2009 Aug 6;460(7256):711-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19661910</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2009 Dec;83(23):12084-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19759148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Sep-Oct;1789(9-10):495-517</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19781674</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2009 Dec 4;394(3):544-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19782089</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2010 May 25;401(1):29-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20202661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Cell. 2010 Jul;1(7):688-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21203940</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 2011 Apr 6;585(7):1049-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21382373</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2009 Jul;15(7):1314-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19458034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Indiana</li>
<li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Yang, Dong" sort="Yang, Dong" uniqKey="Yang D" first="Dong" last="Yang">Dong Yang</name>
</region>
<name sortKey="Giedroc, David P" sort="Giedroc, David P" uniqKey="Giedroc D" first="David P" last="Giedroc">David P. Giedroc</name>
<name sortKey="Leibowitz, Julian L" sort="Leibowitz, Julian L" uniqKey="Leibowitz J" first="Julian L" last="Leibowitz">Julian L. Leibowitz</name>
<name sortKey="Liu, Pinghua" sort="Liu, Pinghua" uniqKey="Liu P" first="Pinghua" last="Liu">Pinghua Liu</name>
<name sortKey="Wudeck, Elyse V" sort="Wudeck, Elyse V" uniqKey="Wudeck E" first="Elyse V" last="Wudeck">Elyse V. Wudeck</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002990 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002990 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:25462342
   |texte=   SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:25462342" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.

SHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequences.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki